echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > The Upstream and Downstream products of Entacapone

    The Upstream and Downstream products of Entacapone

    • Last Update: 2023-05-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Entacapone is a medication used to treat Parkinson's disease.
    It is an adjunct therapy to levodopa/carbidopa, which helps to increase the amount of levodopa that reaches the brain and to delay the onset of Parkinson's symptoms.
    In the chemical industry, entacapone is used as an intermediate in the production of other pharmaceuticals and fine chemicals.


    Upstream Products


    The upstream products of entacapone are the raw materials that are used to produce it.
    The main raw material used in the production of entacapone is precursor compound 2,3-dimethyl-1,4-benzoxazepine.
    This compound is synthesized through several steps involving the protection and deprotection of functional groups.
    The benzoxazepine is then treated with different reagents to form the final product, entacapone.


    Downstream Products


    The downstream products of entacapone are the final products that are made using it as an intermediate.
    These products are used in the pharmaceutical and chemical industries.
    One of the main downstream products of entacapone is carbidopa, which is another medication used to treat Parkinson's disease.
    Carbidopa works by increasing the amount of levodopa that enters the brain and by delaying the release of levodopa into the bloodstream.


    Another downstream product of entacapone is HMPA ( hexamethylpharmacide), which is commonly used as a polar protic solvent in the pharmaceutical industry.
    HMPA can be used in the purification of various compounds and is also used as an intermediate in the production of other drugs.


    There are also other intermediates and fine chemicals that are produced using entacapone as a starting material such as lidocaine, benzatropine, and alfentanil.
    These compounds have different applications in the pharmaceutical and chemical industries.


    Manufacturing Process


    The manufacturing process of entacapone involves several steps, including the synthesis of the precursor compound 2,3-dimethyl-1,4-benzoxazepine, and its transformation into the final product.
    The synthesis of the benzoxazepine is carried out through several steps, including protection and deprotection of functional groups and treatment with different reagents.


    The manufacturing process of entacapone is carried out in a well-equipped chemical laboratory under strict quality control measures.
    The quality of the raw materials used in the manufacturing process is carefully checked, and the final product is tested for purity and efficiency.


    Market and Trade


    Entacapone is a prescription drug and is available only through a healthcare professional.
    The demand for entacapone is driven by the growing population of Parkinson's patients.
    The market for Parkinson's disease treatment is expected to grow significantly over the next few years as the population ages.


    As for trade, entacapone is mainly traded by the pharmaceutical industry.
    It is usually imported and exported in bulk form and is supplied to pharmaceutical companies for further processing into the final product.


    Conclusion


    Entacapone is a crucial intermediate in the production of various pharmaceuticals and fine chemicals.
    It is used as a starting material in the synthesis of downstream products such as carbidopa and HMPA.
    The manufacturing process of entacapone involves several steps, including the synthesis of the precursor compound 2,3-dimethyl-1,4-benzoxazepine, and its transformation into the final product.
    The market for entacapone is expected to grow significantly over the next few years as the population ages, and it is mainly traded by the pharmaceutical industry.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.